22nd Century Group, Inc. (NYSE:XXII) is a biotechnology company focusing on developing, marketing and licensing genetically-modified cannabis/ hemp/ marijuana plants as well as tobacco plants. Their cannabis focuses on producing hemp plants with low levels of thc for us as food, oil, fabric and more. Additionally, 22nd Century Group’s cannabis division works to produce marijuana plant varieties with high CBD levels for the medical cannabis industry. Their tobacco division focuses on producing tobacco plants with low levels of nicotine while maintaining flavor, smell and smokability.